Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Relay Therapeutics Inc (NASDAQ: RLAY) closed at $7.46 in the last session, up 0.81% from day before closing price of $7.40. In other words, the price has increased by $0.81 from its previous closing price. On the day, 3.02 million shares were traded. RLAY stock price reached its highest trading level at $7.6225 during the session, while it also had its lowest trading level at $7.3627.
Ratios:
We take a closer look at RLAY’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 15.64 and its Current Ratio is at 15.64. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on September 10, 2024, Upgraded its rating to Buy and sets its target price to $16 from $10.60 previously.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 27 ’24 when THOMAS J CATINAZZO bought 6,162 shares for $7.46 per share.
Catinazzo Thomas sold 10,780 shares of RLAY for $92,316 on Jul 29 ’24. The Chief Financial Officer now owns 319,650 shares after completing the transaction at $8.56 per share. On Jul 30 ’24, another insider, Rahmer Peter, who serves as the insider of the company, sold 15,128 shares for $8.28 each. As a result, the insider received 125,260 and left with 405,637 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLAY now has a Market Capitalization of 1211959040 and an Enterprise Value of 361502144. For the stock, the TTM Price-to-Sale (P/S) ratio is 34.42 while its Price-to-Book (P/B) ratio in mrq is 1.46. Its current Enterprise Value per Revenue stands at 10.268 whereas that against EBITDA is -0.983.
Stock Price History:
Over the past 52 weeks, RLAY has reached a high of $12.14, while it has fallen to a 52-week low of $5.70. The 50-Day Moving Average of the stock is -0.67%, while the 200-Day Moving Average is calculated to be -8.86%.
Shares Statistics:
According to the various share statistics, RLAY traded on average about 1.87M shares per day over the past 3-months and 2121560 shares per day over the past 10 days. A total of 127.46M shares are outstanding, with a floating share count of 111.73M. Insiders hold about 31.23% of the company’s shares, while institutions hold 55.77% stake in the company. Shares short for RLAY as of 1726185600 were 9924227 with a Short Ratio of 5.31, compared to 1723680000 on 9053519. Therefore, it implies a Short% of Shares Outstanding of 9924227 and a Short% of Float of 7.46.
